regeneron pharmaceuticals
(REGN:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)
Executive Profile*
Alfred G. Gilman M.D., Ph.D.Co-Founder, Director, Chairman of Corporate Governance & Compliance Committee and Member of Technology Committee, Regeneron Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 26 board members in 2 different organizations across 2 different industries. See Board Relationships |
| 70 | $515,425 |
Background*
Dr. Alfred G. Gilman, M.D, Ph.D. is the Co-Founder of Regeneron Pharmaceuticals, Inc. Dr. Gilman has been the Raymond and Ellen Willie Professor of Molecular Neuropharmacology and Chairman of the Department of Pharmacology at The University of Texas Southwestern Medical Center at Dallas since 1981. He serves as an Executive Vice President for Academic Affairs and Provost, The University of Texas Southwestern Medical Center at Dallas. He has been the Dean of the University ...
Corporate Headquarters*777 Old Saw Mill River RoadTarrytown, New York 10591 United States Phone: 914-347-7000 Fax: 914-347-2113 Board Members Memberships*1990-Present Co-Founder, Director, Chairman of Corporate Governance & Compliance Committee and Member of Technology Committee 1995-Present Director, Chairman of Science & Technology Committee and Member of Public Policy & Compliance Committee
Education*Honors Degree 1990 The University of Chicago BS 1962 Yale University Honors Degree 1997 Yale University PhD 1969 Case Western Reserve University MD 1969 Case Western Reserve University Honors Degree 1995 Case Western Reserve University Honors Degree 1999 University of Miami
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*
|
| Recently Viewed | |||
| REGN:US | $250.31 USD | -4.56 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Richard F. Pops | Chairman and Chief Executive Officer Alkermes plc | $775.0K |
| Jean-Jacques Bienaimé | Chief Executive Officer and Director BioMarin Pharmaceutical Inc. | $821.1K |
| N. Anthony Coles M.D., M.P.H. | Chairman, Chief Executive Officer and President Onyx Pharmaceuticals, Inc. | $740.0K |
| Jeffrey M. Leiden M.D., Ph.D. | Chairman, Chief Executive Officer and President Vertex Pharmaceuticals Incorporated | $1.0M |
| David E. I. Pyott | Chairman, Chief Executive Officer and President Allergan Inc. | $1.3M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
